Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.

Previous studies suggest that carotenoids and tocopherols (vitamin E compounds) may be inversely associated with prostate cancer risk, yet little is known about how they affect prostate cancer progression and survival. We investigated whether serum alpha-tocopherol, beta-carotene, and retinol concentrations, or the alpha-tocopherol and beta-carotene trial supplementation, affected survival of men diagnosed with prostate cancer during the alpha-Tocopherol, beta-Carotene Cancer Prevention Study, a randomized, double-blind, placebo-controlled primary prevention trial testing the effects of beta-carotene and alpha-tocopherol supplements on cancer incidence in adult male smokers in southwestern Finland (n = 29,133). Prostate cancer survival was examined using the Kaplan-Meier method with deaths from other causes treated as censoring, and using Cox proportional hazards regression models with hazard ratios (HR) and 95% confidence intervals (CI) adjusted for family history of prostate cancer, age at randomization, benign prostatic hyperplasia, age and stage at diagnosis, height, body mass index, and serum cholesterol. As of April 2005, 1,891 men were diagnosed with prostate cancer and 395 died of their disease. Higher serum alpha-tocopherol at baseline was associated with improved prostate cancer survival (HR, 0.67; 95% CI, 0.45-1.00), especially among cases who had received the alpha-tocopherol intervention of the trial and who were in the highest quintile of alpha-tocopherol at baseline (HR, 0.51; 95% CI, 0.20-0.90) or at the 3-year follow-up measurement (HR, 0.26; 95% CI, 0.09-0.71). Serum beta-carotene, serum retinol, and supplemental beta-carotene had no apparent effects on survival. These findings suggest that higher alpha-tocopherol (and not beta-carotene or retinol) status increases overall prostate cancer survival. Further investigations, possibly including randomized studies, are needed to confirm this observation.

[1]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[2]  J. Manson,et al.  Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. , 2009, JAMA.

[3]  J. Crowley,et al.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.

[4]  D. Hunter,et al.  Textbook of cancer epidemiology , 2003 .

[5]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[6]  Emily White,et al.  Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort , 2008, Cancer Causes & Control.

[7]  C. Tangen,et al.  Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916. , 2007, The Journal of urology.

[8]  N. Barnard,et al.  Diet and survival after prostate cancer diagnosis. , 2007, Nutrition reviews.

[9]  F. Berrino,et al.  Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. , 2007, The American journal of clinical nutrition.

[10]  Stacey A. Kenfield,et al.  Diet and Lifestyle Interventions in Active Surveillance Patients with Favorable-Risk Prostate Cancer , 2007, Current treatment options in oncology.

[11]  Karla A. Lawson,et al.  Supplemental and Dietary Vitamin E Intakes and Risk of Prostate Cancer in a Large Prospective Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  Karla A. Lawson,et al.  Serum and Dietary Vitamin E in Relation to Prostate Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[13]  Amy Subar,et al.  Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. , 2007, Journal of the National Cancer Institute.

[14]  E. Horwitz,et al.  Vitamin E succinate inhibits NF‐κB and prevents the development of a metastatic phenotype in prostate cancer cells: Implications for chemoprevention , 2007, The Prostate.

[15]  W. Demark-Wahnefried,et al.  Dietary intervention in the management of prostate cancer , 2007, Current opinion in urology.

[16]  Nilanjan Chatterjee,et al.  Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2007, Cancer Epidemiology Biomarkers & Prevention.

[17]  Karla A. Lawson,et al.  Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. , 2006, The American journal of clinical nutrition.

[18]  Peter McCarron,et al.  A Prospective Investigation of Height and Prostate Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[19]  E. Rimm,et al.  Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States) , 2006, Cancer Causes & Control.

[20]  R. Hayes,et al.  Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. , 2006, Journal of the National Cancer Institute.

[21]  E. Giovannucci,et al.  Role of diet in prostate cancer development and progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  E. Messing,et al.  Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. , 2005, Cancer research.

[23]  N. Mendell,et al.  Intensive lifestyle changes may affect the progression of prostate cancer. , 2005, The Journal of urology.

[24]  S. Yusuf,et al.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.

[25]  P. Kantoff,et al.  Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. , 2005, Cancer research.

[26]  D. Albanes,et al.  Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland) , 2003, Cancer Causes & Control.

[27]  Nea Malila,et al.  Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.

[28]  G. Omenn,et al.  The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  J. Potter,et al.  Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. , 2003, American journal of epidemiology.

[30]  Jack A. Taylor,et al.  Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  L. Klotz,et al.  Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. , 2002, Journal of Urology.

[32]  D. Albanes,et al.  The Finnish Cancer Registry as Follow-Up Source of a Large Trial Cohort , 2002, Acta oncologica.

[33]  J. Manson,et al.  Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States) , 2000, Cancer Causes & Control.

[34]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[35]  C. Gogos,et al.  Dietary omega‐3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy , 1998, Cancer.

[36]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[37]  B. Henderson,et al.  Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. , 1991, British Journal of Cancer.

[38]  D. Milne,et al.  Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. , 1986, Clinical chemistry.

[39]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[40]  D. Albanes,et al.  Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. , 2001, The Prostate.

[41]  G. Omenn.  Micronutrients (vitamins and minerals) as cancer-preventive agents. , 1996, IARC scientific publications.

[42]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[43]  M. Singer,et al.  Nutritional Epidemiology , 2020, Definitions.

[44]  G. Möller,et al.  Multicentre Study of a New Enzymatic Method of Cholesterol Determination , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.